HomeCLDX • NASDAQ
add
Celldex Therapeutics, Inc.
Previous close
$26.53
Day range
$24.03 - $26.28
Year range
$22.93 - $53.18
Market cap
1.62B USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.19M | 110.35% |
Operating expense | 10.05M | 22.30% |
Net income | -42.12M | -10.09% |
Net profit margin | -1.32K | 47.66% |
Earnings per share | -0.64 | 20.99% |
EBITDA | -51.34M | -26.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 756.00M | 221.23% |
Total assets | 823.18M | 193.72% |
Total liabilities | 37.27M | 11.14% |
Total equity | 785.90M | — |
Shares outstanding | 66.34M | — |
Price to book | 2.24 | — |
Return on assets | -15.62% | — |
Return on capital | -16.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -42.12M | -10.09% |
Cash from operations | -55.34M | -191.35% |
Cash from investing | 47.76M | 310.08% |
Cash from financing | 1.24M | 382.10% |
Net change in cash | -6.34M | 10.58% |
Free cash flow | -31.26M | -621.49% |
About
Founded
1983
Headquarters
Website
Employees
160
